Open AccessDecitabine activates type I interferon signaling to inhibit p53‐deficient myeloid malignant cells
Author(s) -
Wu Jiale,
Li Yuntong,
Wu Jiaqi,
Song Huaxin,
Tang Yigang,
Yan Ni,
Wu Lili,
Zhang Sujiang,
Chang ChunKang,
Lu Min
Publication year - 2021
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.593
Subject(s) - decitabine , cancer research , interferon , medicine , myeloid , myeloid leukemia , chemistry , immunology , gene , biochemistry , dna methylation , gene expression
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom